Jianfeng Group Pro 2015-028 (Announcement of Resolutions of the 5th Session of the 9th Board of Directors)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2015-028
Bond Abbreviations: 13 Peak 01 Bond Code: 122227
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement of the Fifth Session of the Ninth Board of Directors
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the relevant provisions of the company's Articles of Association.
(II) 2015# On October 19, 38, the company issued the notice of the board meeting by fax, e-mail and personal service.
(III) 2015# On October 30, 42, the board meeting was held by means of a communication vote.
(IV) 9directors who should attend this board meeting and 9 directors who actually attended the meeting.
2. Board Meeting Review1
, "Company 2015 Third Quarter Report"
After review and voting, the Board of Directors passed the "Company 2015Third Quarter Report".
Voting result: 9votes in favor, 0 votes against and 0 abstentions.
Company 2015Third Quarter Report is available on the Shanghai Stock Exchange website (www.sse.com.cn).
2, Proposal
to Participate in the Relocation of Jinhua Maternal and Child Health Hospital According to the Notice of the General Office of the State Council on Further Encouraging and Guiding Social Capital to Set up Medical Institutions and other relevant policies. According to the company's strategic policy, combined with the needs of the development of the company's pharmaceutical business sector, the company intends to apply to relevant departments to participate in the relocation of Jinhua Maternal and Child Health Hospital.Voting result: 9
votes in favor, 0 votes against, 0 abstentions. For details of
, please refer to the Announcement on Participating in the Relocation of Jinhua Maternal and Child Health Hospital (P.2015 -029).
3, Proposal
on Subsidiary Construction of Modern Pharmaceutical Logistics Center The Board of Directors agreed that subsidiary Jinhua Pharmaceutical Co., Ltd. would invest 66.47 million yuan to build a modern pharmaceutical logistics center in accordance with the requirements of the new GSP for pharmaceutical circulation enterprises on the basis of the land, factory building and other related assets of 599Jinxing South Street, Jinhua City.
Voting Result: 9votes in favor, 0 votes against, 0 abstentions.
4, Proposal on Adding Members of Special Committees of the Board of Directors # The 100 meeting agreed to add Mr. Huang Conyun as a member of the Audit Committee, Remuneration and Evaluation Committee, and Nomination Committee of the 9th Board of Directors of the company. Chairman of the Nomination Committee.
voting result: 9
votes in favor, 0 votes against and 0 abstentions.is hereby announced.
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
October 30, 2015
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page